- Corporate Officers - E
- Eck Stephen L.
Insider Trading History of Eck Stephen L.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Eck Stephen L. since 2020.
This trader's CIK number is 1669041.
At the time of last reporting, Eck Stephen L. was the Chief Medical Officer of Macrogenics Inc. (stock ticker symbol MGNX).
Also see all insider trading activities at Macrogenics Inc.
Note that in the past
Eck Stephen L. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Macrogenics Inc (MGNX) by Eck Stephen L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | MGNX | 0 | $0 | 0 | $0 | 27,833 | $0 |
| 2024 | MGNX | 0 | $0 | 0 | $0 | 16,670 | $0 |
Yearly summary of insider trading at Luminex Corp (LMNX) by Eck Stephen L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | LMNX | 4,487 | $100,513 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Eck Stephen L.:
1. Macrogenics Inc (MGNX)
2. Luminex Corp (LMNX)
Table 1. Insider trading of Macrogenics Inc (MGNX) by Eck Stephen L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-15 | MGNX | Option Ex | 16,665 | .00 | 0 |
| 2025-02-08 | MGNX | Option Ex | 11,168 | .00 | 0 |
| 2024-02-15 | MGNX | Option Ex | 16,670 | .00 | 0 |
Table 2. Insider trading of Luminex Corp (LMNX) by Eck Stephen L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-11-25 | LMNX | Buy | 4,487 | 22.40 | 100,513 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Eck Stephen L.
(Chief Medical Officer of Macrogenics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.